From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. Respiratory Infections>
  4. Archives

Respiratory Infections: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 51-75 of 745 are shown

Rotavirus Outbreaks in Retirement Communities

Rotavirus probably is an underrecognized pathogen in older adults.

Most Sinus Complaints Don't Require Antibiotics

The data and the guidelines agree: Avoid prescribing antibiotics for most patients with the usual complaints of congestion and facial pain.

ACIP Recommends Pneumococcal Conjugate Vaccine for HIV-Infected Adults

PCV13 should be given at least 8 weeks before the first PPSV23 dose or, in patients with previous PPSV23 vaccination, at least 1 year after PPSV23 administration.

Flucelvax

The FDA has approved a seasonal influenza vaccine manufactured using mammalian cell culture.

Effectiveness of a 10-Valent Pneumococcal Vaccine in Finland

A 10-valent pneumococcal conjugate vaccine was very effective, whether given as two or three doses plus booster, in infants aged <7 months.

Patterns of Pertussis Among Adults

Women, obese people, and people with asthma are at risk — or possibly just more likely to be recognized as having the infection.

Environmental Risk Factors for PCP?

A recent study suggests a link between higher outdoor temperatures and hospital admissions for PCP.

Statins and the Risk for Death from Pneumonia

Two retrospective studies suggested that risk was reduced in statin users, but a large, controlled trial is needed to confirm this effect.

Is the 13-Valent Pneumococcal Conjugate Vaccine Cost-Effective in High-Risk Groups?

No — at least not when used in conjunction with the 23-valent polysaccharide vaccine used in the U.K.'s existing program.

Balancing the Risks and Benefits of Early ART Initiation in HIV-Infected Patients with TB

A secondary analysis from the SAPiT trial reinforces current recommendations.

Proton-Pump Inhibitor Use and Risk for Community-Acquired Pneumonia

In patients with community-acquired pneumonia, PPI use was associated with a twofold increased risk for infection with oropharyngeal bacteria but not other pathogenic agents.

Subclinical Influenza A in Pigs at Fairs

Influenza A virus was recovered from seemingly healthy pigs at 19% of agricultural fairs in Ohio over a 3-year period.

Novel Coronavirus in the Middle East: More Details

This case provides another example of an animal coronavirus causing severe disease in humans.

Patient vs. Environmental Factors in Mycobacterium avium Complex Lung Disease

A susceptible host matters more than an unusual environmental dose, according to a case-control study.

Long-Term Outcome for Children with Pleural Empyema Is Good

After 1 month, more than 25% have abnormal clinical findings; by 12 months, most abnormal findings resolve and quality of life is normal.

Linezolid for XDR-TB?

In a small phase IIa study, most patients experienced culture conversion when linezolid was added to their existing regimens, but drug-related adverse events were common.

Flu Vaccine Benefit Is "Modest"

The antigenically well-matched influenza vaccine from the 2010–2011 season was about 60% protective.

Novel Coronavirus Surfaces in the Middle East

A newly identified coronavirus has been implicated in two cases of severe respiratory illness, one of them fatal.

Thalidomide Quiets Cough in Patients with Idiopathic Pulmonary Fibrosis

A 12-week course yielded significant improvement from baseline.

Treating Active TB in HIV-Infected Patients

Antiretroviral therapy improves TB treatment outcomes among HIV-infected individuals with active pulmonary TB. Individuals not receiving ART benefit from daily rifamycin dosing during the intensive phase of TB treatment and ≥8 months of rifamycin therapy.

Vitamin D Does Not Prevent Upper Respiratory Tract Infections

No benefit of supplementation was noted, either in incidence or severity of URTIs.

Use of Live-Attenuated Influenza Vaccine for Healthcare Providers

A recent guidance statement from the Society for Healthcare Epidemiology of America supports the use of live-attenuated influenza vaccine for most healthcare workers.

Gabapentin for Refractory Chronic Cough?

Patients with hypersensitive central cough reflex responded well to 10 weeks of therapy.

Safety of Influenza Vaccination During Early Pregnancy

Risk for fetal malformations was unaffected by maternal first-trimester vaccination.

Cannot Rely on Complete Blood Cell Count to Rule Out Early Onset Neonatal Sepsis

In the largest study to date, researchers found that a "normal" CBC is not sensitive enough to rule out early onset neonatal sepsis.

Items 51-75 of 745 are shown

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?





Copyright © 2013. Massachusetts Medical Society. All rights reserved.